13FPulse
BT

BTSG BRIGHTSPRING HEALTH SERVICES

2026Q2 · CUSIP 10950A106 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
410
Institutions that reported holding it to the SEC
Net increase in holders
+76
Last quarter 334 → now 410
How unusual is that
Top 5%
Stronger buying than 97% of US stocks
What the filings say, in one paragraph

410 funds held BTSG at the end of 2026Q2, up 76 from the quarter before. That is stronger buying than 97.3% of US stocks — among the most piled-into names this quarter. On the business itself, revenue over the last 12 months was $13.6B(YoY +28.0%), the P/E is 43.0x, return on equity is 15.7%. BTSG has had 7 buying rushes in its history, and the price moved +54.5% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2024Q2: holders=96 2024Q3: holders=127 2024Q4: holders=136 2025Q1: holders=161 2025Q2: holders=201 2025Q3: holders=227 2025Q4: holders=285 2026Q1: holders=334 2026Q2: holders=410 -76 -38 +0 +38 +76 86259431 24Q224Q324Q425Q125Q225Q325Q426Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 7 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 5%
2026Q1 Top 5%
2025Q4 Top 10% +43.6%
2025Q3 Top 20% +30.1% +86.8%
2025Q2 Top 10% +38.6% +78.2%
2025Q1 Top 10% -3.9% +30.1%
2024Q3 Top 10% +4.3% +22.7%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
194
Change in large funds
+42
Total value they hold
$14.4B
Funds buying for the first time
123
Funds that sold out entirely
47
Price change that quarter
+7.2%
Funds holding puts (bearish)
5
Funds holding calls (bullish)
6

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
43.0
EPS (TTM)
$1.40
EPS YoY
+351.6%
Revenue (TTM)
$13.6B
Revenue YoY
+28.0%
Net margin
2.3%
ROE
15.7%
Debt ratio
68.0%
FCF (TTM)
$412M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2023-03-31: EPS -0.18 2023-06-30: EPS 0.03 2023-09-30: EPS -1.11 2023-12-31: EPS -0.05 2024-03-31: EPS -0.26 2024-06-30: EPS 0.10 2024-09-30: EPS -0.04 2024-12-31: EPS 0.11 2025-03-31: EPS 0.14 2025-06-30: EPS 0.13 2025-09-30: EPS 0.26 2025-12-31: EPS 0.34 2026-03-31: EPS 0.67 0B 1.8B 3.6B $B -1.22 -0.24 0.74 2023202420252026 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
37 60 83 20252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-101M47M194M 2023202420252026
Latest quarter $101M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-03-31 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.